ADIA New Exporters' Grant - Applications open
13th Jun 18
ADIA has established a new grant program to support emerging local dental product manufacturers attend the worlds’ largest dental exhibition, IDS Cologne. The grant assists recipients to find international distributors for their products
Key Issues For The Dental Industry —
The Australian Dental Industry Association (ADIA) has long supported business that manufacture innovative dental products. To support those businesses reach new overseas markets, ADIA has established the ADIA New Exporters' Grant.
The ADIA New Exporters' Grant is all about assisting local manufacturers to better understand the global market for dental products. To this end, the grant’s primary focus is to allow these businesses to reach out to new distributors in key markets by attending the IDS Cologne dental exhibition.
There is no better platform to meet potential distributors than the IDS Cologne dental exhibition when, every two years, more than 2,000 exhibitors from more than fifty countries gather along with more than 150,000 stakeholders from across the dental community.
The ADIA New Exporters' Grant provides financial assistance for a business to attend the IDS Cologne dental exhibition for the first time.
With a focus on supporting first-time exporters, the ADIA New Exporters' Grant will be of great assistance to those businesses with market-ready products.
Networking is one of the biggest benefits of attending the IDS Cologne exhibition. The ADIA New Exporters' Grant will let you build relationships in person, and trade shows provide a great way to meet new people and catch up with those you already know. You’ll have the opportunity to meet new customers or business partners and strengthen relationships with other manufacturers and exporters that face the same challenges as you.
Applications for this year's ADIA New Exporters' Grant close on 31 July 2018. The recipient will be named on 15 August 2018.
The grant will be awarded every two years when IDS Colgone is convened.
Member Engagement —
ADIA provides leadership, strategy, advocacy and support. Our members set our agenda, fund our activities and directly benefit from the results. With respect to the Association's work to support Australian manufacturers looking to develop new export markets, the team in the ADIA national office receive advice and guidance from members serving on the ADIA-MIG Manufacturers' Interest Group and updates are provided at the quarterly ADIA State Branch Briefings.
Further Information —
To keep up to date with the latest market statistics subscribe to the Twitter feed @AusDental or follow us on Facebook at www.facebook.com/dental.industry. Alternatively, you can contact the Association via email at email@example.com or by telephone on 1300 943 094.
Currency Of Information & Disclaimer —
This update was issued on 13 June 2018 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, images and where stated.
|A —.. A D I A . .S T R A T G E G I C . .A L L I A N C E S
1st Feb 18
Thanks to ADIA's advocacy, the dental industry looks set to escape a proposed TGA reform that would require patient information 'cards' to be provided to patients, a reform that ignores advances in electronic patient records.
8th Jun 18
A new analysis of the new medical devices tax lists the twenty federal electorates with largest number of businesses that will be affected by this new impost on supplying innovative medical devices.